Hormonal Contraceptives Market: Global Industry Analysis and Forecast (2022-2029)


Hormonal Contraceptives Market is expected to reach US$ 28.45 Bn. at a CAGR of 5.4% during the forecast period 2029.

The global Hormonal Contraceptive market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Hormonal Contraceptives report also provides trends by market segments, technology, and investment with a competitive landscape.

Hormonal Contraceptives Market

To know about the Research Methodology :- Request Free Sample Report

Hormonal Contraceptives Market Overview:

Hormonal Contraceptives are pills or medical devices used to control birth. It works by preventing the body from producing an egg so there is no egg for sperm to fertilize, and pregnancy cannot occur. Hormonal contraceptive pills can also help with irregular, painful, or heavy periods, endometriosis, acne, and premenstrual syndrome (PMS). The specific side effects diverge extensively among individuals, and different pills cause different side effects. Some common side effects of hormonal contraceptives are spotting, nausea, breast tenderness, and headaches.

Hormonal Contraceptives Market Dynamics:

The major driving factors of the market growth are a surge in Awareness of family planning and the need for preventing unintended pregnancy. The development in hormonal contraception with improved efficacy and fewer side effects is probable to further boost the market growth. Moreover, health issues related to teenage pregnancies, a rise in awareness towards modern contraception methods, an upswing in the use of oral pills as a chief method to prevent unplanned pregnancy is likely to fuel the market growth. However, the availability of substitute contraceptive methods, health risks associated with the use of contraceptives, and lack of social acceptance harmfully affect the market growth.

For instance, in July 2015, Teva Pharmaceutical Industries Ltd launched an educational initiative to create alertness in consumers called the "Perfectly Imperfect" program. In September 2015, Allergan publicized a corporation with the U.S. Women's Health Alliance (USWHA), is an organization that focuses on promoting affordable and high-quality healthcare services for women. This agreement will make LILETTA, an intrauterine device of Allergan, available to women across USWHA Health Care Groups in the U.S.

Hormonal Contraceptives Market Segment Analysis:

By Type, the segment is divided into Pills, Injectable, vaginal Rings, Intrauterine Device, Implant, and Other. In 2019, the pills segment accounted for the largest market share and dominance throughout the forecast period. The growth of the segment can be accredited to the easy and simple mode of administration, easy availability of products, high awareness about pills due to initial market entry as compared to long-acting devices, and high efficiency of about 99% on timely ingesting

IUDs are likely to observe the wildest growth during the forecast period due to the mounting adoption of long-acting methods of contraception. More than 99.0% effectivity, longer action, no effect of the device on breastfeeding, and normal fertility after removal of the device are some of the factors attributable to the noteworthy growth of the segment.

By Distribution Channel, the segment is categorized into hospital pharmacy, retail pharmacy, online Channel. Hospital pharmacy account for a major share in hormonal contraceptives due to high exposure of patient counselling and various treatments available on the go.

Hormonal Contraceptives Market Regional Insights:

North America led the global market in 2019 and is expected to continue its position during the forecast period. This is due to high per capita income, the strong presence of market players, advanced awareness about sexual health, and a large number of unintended pregnancies.

The Asia Pacific is probable to witness the fastest growth during the forecast period. A large fertile population, the introduction of new female contraception devices, rise in an asset by market players, and strong economic growth are the major factors supplementing the regional growth.

A growing number of product promotions, promising government initiatives, and awareness among the population is projected to propel the Middle East and Africa market. For instance, in May 2013, Merck & Co. and its public segment partners prolonged the agreement to enlarge access to Implanon. As per this agreement, the company reduced the price of the implant and its next-generation drug Implanon NXT (etonogestrel) by approximately 50% for the next 6 years in 70 poor countries.

The objective of the report is to present a comprehensive analysis of the global Hormonal Contraceptives market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global Hormonal Contraceptives market dynamics, structure by analyzing the market segments and project the global Hormonal Contraceptives market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Hormonal Contraceptives market make the report investor’s guide.

Hormonal Contraceptives Market Scope: Inquire before buying

Global Hormonal Contraceptives Market 4

Hormonal Contraceptives Market, by Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America

Hormonal Contraceptives Market Key Players

• Female Health Company
• Teva Pharmaceutical Industries Limited
• Bayer AG,
• Pfizer, Inc.,
• Mylan N.V.,
• Johnson & Johnson,
• Ansell LTD.,
• Mayer Laboratories,
• Merck & Co., Inc.,
• Church & Dwight, Co., Inc.
• Amgen (U.S.),
• Bayer Healthcare Pharmaceuticals (Germany),
• Cipla Limited (India),
• Glenmark Pharmaceuticals (India),
• Lupin Pharmaceuticals, Inc (India),
• Novartis AG (Switzerland),
• Pfizer, Inc. (U.S.),
• Piramal Healthcare Limited (India),
• Sun Pharmaceutical Industries Ltd. (India),

Frequently Asked Questions:

1. Which region has the largest share in Global Hormonal Contraceptives Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global Hormonal Contraceptives Market?
Ans: The Global Hormonal Contraceptives Market is growing at a CAGR of 5.4% during forecasting period 2022-2029.

3. What is scope of the Global Hormonal Contraceptives market report?
Ans: Global Hormonal Contraceptives Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Hormonal Contraceptives market?
Ans: The important key players in the Global Hormonal Contraceptives Market are – Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG,, Pfizer, Inc.,, Mylan N.V.,, Johnson & Johnson,, Ansell LTD.,, Mayer Laboratories,, Merck & Co., Inc.,, Church & Dwight, Co., Inc., Amgen (U.S.),, Bayer Healthcare Pharmaceuticals (Germany),, Cipla Limited (India),, Glenmark Pharmaceuticals (India),, Lupin Pharmaceuticals, Inc (India),, Novartis AG (Switzerland),, Pfizer, Inc. (U.S.),, Piramal Healthcare Limited (India),, Sun Pharmaceutical Industries Ltd. (India), and

5. What is the study period of this market?
Ans: The Global Hormonal Contraceptives Market is studied from 2021 to 2029. 




1. Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Hormonal Contraceptives Market Size, by Market Value (US$ Mn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2021
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Hormonal Contraceptives Market
3.4. Geographical Snapshot of the Hormonal Contraceptives Market, By Manufacturer share
4. Global Hormonal Contraceptives Market Overview, 2021-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Types
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Hormonal Contraceptives Market
5. Supply Side and Demand Side Indicators
6. Global Hormonal Contraceptives Market Analysis and Forecast, 2021-2029
6.1. Global Hormonal Contraceptives Market Size & Y-o-Y Growth Analysis.
7. Global Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
7.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
7.1.1. Pills,
7.1.2. Injectable
7.1.3. vaginal Rings
7.1.4. Intrauterine Device
7.1.5. Implant
7.1.6. Other
7.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
7.2.1. Hospital Clinic
7.2.2. Retail Clinic
7.2.3. Online
8. Global Hormonal Contraceptives Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. Asia Pacific Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
9.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
9.1.1. Pills,
9.1.2. Injectable
9.1.3. vaginal Rings
9.1.4. Intrauterine Device
9.1.5. Implant
9.1.6. Other
9.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
9.2.1. Hospital Clinic
9.2.2. Retail Clinic
9.2.3. Online
10. North America Hormonal Contraceptives Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
11.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
11.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
12. Canada Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
12.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
12.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
13. Mexico Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
13.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
13.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
14. Europe Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
14.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
14.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
15. Europe Hormonal Contraceptives Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
16.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
16.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
17. France Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
17.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
17.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
18. Germany Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
18.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
18.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
19. Italy Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
19.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
19.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
20. Spain Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
20.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
20.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
21. Sweden Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
21.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
21.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
22. CIS Countries Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
22.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
22.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
23. Rest of Europe Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
23.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
23.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
24. Asia Pacific Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
24.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
24.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
25. Asia Pacific Hormonal Contraceptives Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
26.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
26.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
27. India Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
27.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
27.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
28. Japan Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
28.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
28.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
29. South Korea Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
29.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
29.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
30. Australia Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
30.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
30.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
31. ASEAN Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
31.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
31.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
32. Rest of Asia Pacific Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
32.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
32.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
33. Middle East Africa Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
33.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
33.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
34. Middle East Africa Hormonal Contraceptives Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
35.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
35.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
36. GCC Countries Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
36.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
36.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
37. Egypt Hormonal Contraceptives e Market Analysis and Forecasts, 2021-2029
37.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
37.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
38. Nigeria Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
38.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
38.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
39. Rest of ME&A Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
39.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
39.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
40. South America Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
40.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
40.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
41. South America Hormonal Contraceptives Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
42.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
42.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
43. Argentina Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
43.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
43.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
44. Rest of South America Hormonal Contraceptives Market Analysis and Forecasts, 2021-2029
44.1. Market Size (Value) Estimates & Forecast By Type, 2021-2029
44.2. Market Size (Value) Estimates & Forecast By Distribution Channel, 2021-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Hormonal Contraceptives Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Types and R&D Investment
45.2.2. New Type Launches and Type Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile : Key Players
45.3.1. Female Health Company
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Type Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Teva Pharmaceutical Industries Limited
45.3.3. Bayer AG,
45.3.4. Pfizer, Inc.,
45.3.5. Mylan N.V.,
45.3.6. Johnson & Johnson,
45.3.7. Ansell LTD.,
45.3.8. Mayer Laboratories,
45.3.9. Merck & Co., Inc.,
45.3.10. Church & Dwight, Co., Inc.
45.3.11. Amgen (U.S.),
45.3.12. Bayer Healthcare Pharmaceuticals (Germany),
45.3.13. Cipla Limited (India),
45.3.14. Glenmark Pharmaceuticals (India),
45.3.15. Lupin Pharmaceuticals, Inc (India),
45.3.16. Novartis AG (Switzerland),
45.3.17. Pfizer, Inc. (U.S.),
45.3.18. Piramal Healthcare Limited (India),
45.3.19. Sun Pharmaceutical Industries Ltd. (India),
46. Primary Key Insights
  • INQUIRE BEFORE BUYING